Personalized Therapy for Multiple Myeloma

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Personalized Therapy for Multiple Myeloma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319618722
Publisher: Springer International Publishing Publication: October 30, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319618722
Publisher: Springer International Publishing
Publication: October 30, 2017
Imprint: Springer
Language: English

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

More books from Springer International Publishing

Cover of the book Gender and the Economic Crisis in Europe by
Cover of the book Interpretation of Basic and Advanced Urodynamics by
Cover of the book The Vatican Observatory, Castel Gandolfo: 80th Anniversary Celebration by
Cover of the book Prostate Cancer Survivorship by
Cover of the book New Feminist Perspectives on Embodiment by
Cover of the book Information and Communication Technologies in Tourism 2016 by
Cover of the book Multilevel Selection and the Theory of Evolution by
Cover of the book The Economics of Addictive Behaviours Volume II by
Cover of the book Mathematical Modelling for Teachers by
Cover of the book Urban Design and Representation by
Cover of the book Hope for a Good Life by
Cover of the book Interventions in Pulmonary Medicine by
Cover of the book Yeasts in Natural Ecosystems: Ecology by
Cover of the book Basic Thermochemistry in Materials Processing by
Cover of the book Left Septal Fascicular Block by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy